These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 18982467)
1. Internal radiotherapy using 32P colloid or microsphere for refractory solid tumors. Gao W; Liu L; Teng GJ; Feng GS; Tong GS; Gao NR Ann Nucl Med; 2008 Oct; 22(8):653-60. PubMed ID: 18982467 [TBL] [Abstract][Full Text] [Related]
2. Effects of 90Y-microspheres on liver tumors: comparison of intratumoral injection method and intra-arterial injection method. Lin WY; Tsai SC; Hsieh JF; Wang SJ J Nucl Med; 2000 Nov; 41(11):1892-7. PubMed ID: 11079501 [TBL] [Abstract][Full Text] [Related]
3. [Intratumoral injection of macroaggragated albumin and colloidal 32P for the treatment of hepatocellular carcinoma]. Liu J; Yang C; Shao W; Han J Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):309-11. PubMed ID: 11676882 [TBL] [Abstract][Full Text] [Related]
4. Cellular toxic effects of combination of low dose of cisplatin and interstitial injection of 32P glass microspheres on mouse solid tumor S180. Li WG; Ai H; Chen WL; Jiang LJ; Wu XZ Chin Med J (Engl); 2005 Jul; 118(13):1099-104. PubMed ID: 16098263 [TBL] [Abstract][Full Text] [Related]
5. A novel approach to brachytherapy in hepatocellular carcinoma using a phosphorous32 (32P) brachytherapy delivery device--a first-in-man study. Goh AS; Chung AY; Lo RH; Lau TN; Yu SW; Chng M; Satchithanantham S; Loong SL; Ng DC; Lim BC; Connor S; Chow PK Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):786-92. PubMed ID: 17141975 [TBL] [Abstract][Full Text] [Related]
6. The effect of various therapeutic solutions including colloidal chromic 32P via an intratumoral injection on the tumor physiological parameters of AsPC-1 human pancreatic tumor xenografts in nude mice. Lee I; Lee YH Clin Cancer Res; 1999 Oct; 5(10 Suppl):3139s-3142s. PubMed ID: 10541354 [TBL] [Abstract][Full Text] [Related]
7. Toxicology of intrahepatic arterial administration of interventional phosphorus-32 glass microspheres to domestic pigs. Liu L; Teng G; Zhang D; Song J; He S; Guo J; Fang W Chin Med J (Engl); 1999 Jul; 112(7):632-6. PubMed ID: 11601259 [TBL] [Abstract][Full Text] [Related]
8. [The side effect and complication of intraarterial phosphorus-32 glass microspheres for patients with advanced hepatoma]. Li L; Yan L; Chen X Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1997 Dec; 14(4):376-9. PubMed ID: 11367632 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of the alpha-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model. Vergote I; Larsen RH; de Vos L; Nesland JM; Bruland O; Bjørgum J; Alstad J; Tropé C; Nustad K Gynecol Oncol; 1992 Dec; 47(3):366-72. PubMed ID: 1473751 [TBL] [Abstract][Full Text] [Related]
10. Effects of intralesional 32-P chromic phosphate in refractory patients with head and neck tumours. Alimi KA; Firusian N; Dempke W Anticancer Res; 2007; 27(4C):2997-3000. PubMed ID: 17695485 [TBL] [Abstract][Full Text] [Related]
11. Microsphere radioembolization of liver malignancies: current developments. Bult W; Vente MA; Zonnenberg BA; Van Het Schip AD; Nijsen JF Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):325-35. PubMed ID: 19521312 [TBL] [Abstract][Full Text] [Related]
13. Distribution of intraperitoneally injected microspheres labeled with the alpha-emitter astatine (211At) compared with phosphorus (32P) and yttrium (90Y) colloids in mice. Vergote I; Larsen RH; De Vos L; Winderen M; Ellingsen T; Bjørgum J; Hoff P; Aas M; Tropé C; Nustad K Gynecol Oncol; 1992 Dec; 47(3):358-65. PubMed ID: 1473750 [TBL] [Abstract][Full Text] [Related]
14. An early phase II study of intratumoral P-32 chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases. Firusian N; Dempke W Cancer; 1999 Feb; 85(4):980-7. PubMed ID: 10091778 [TBL] [Abstract][Full Text] [Related]
15. Fibrin glue system for adjuvant brachytherapy of brain tumors with 188Re and 186Re-labeled microspheres. Häfeli UO; Pauer GJ; Unnithan J; Prayson RA Eur J Pharm Biopharm; 2007 Mar; 65(3):282-8. PubMed ID: 17129715 [TBL] [Abstract][Full Text] [Related]
16. An initial clinical study on the efficacy of cisplatin-releasing gelatin microspheres for metastatic liver tumors. Nitta N; Ohta S; Tanaka T; Takazakura R; Toyama T; Sonoda A; Seko A; Furukawa A; Takahashi M; Murata K; Kurumi Y; Tani T; Sakamoto T; Tabata Y Eur J Radiol; 2009 Sep; 71(3):519-26. PubMed ID: 18617345 [TBL] [Abstract][Full Text] [Related]
17. [Implantation brachytherapy with 32P-chromic phosphate-poly (L-lactide) delayed-release particles for prostate cancer in nude mice]. He XJ; Jia RP; Shao GQ; Xu LW; Wang ZZ; Huang PL; Wu JP; Wang J Zhonghua Nan Ke Xue; 2010 Oct; 16(10):872-6. PubMed ID: 21243748 [TBL] [Abstract][Full Text] [Related]
18. Treatment of malignant pericardial effusion with 32P-colloid. Dempke W; Firusian N Br J Cancer; 1999 Aug; 80(12):1955-7. PubMed ID: 10471044 [TBL] [Abstract][Full Text] [Related]
19. [Short- and medium-term clinical effects of CT guided (125)I radioactive seeds implantation in treatment of recurrent/metastatic malignant pelvic tumors]. Zhang FJ; Jiao DC; Li CX Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(43):3063-7. PubMed ID: 19192407 [TBL] [Abstract][Full Text] [Related]
20. [Brachytherapy of solid tumors. Use of chromic phosphate colloid]. Zubillaga M; Boccio J; Nicolini J; Ughetti R; Lanari E; Caro R Acta Physiol Pharmacol Ther Latinoam; 1997; 47(3):179-85. PubMed ID: 9410223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]